$141.120
+0.804 (+0.57%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de PTGX por análisis de gráficos similares
Alphio's PTGX stock price prediction model matches the current Protagonist Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $139.50 (-1.15%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Protagonist Therapeutics Inc?
Protagonist Therapeutics Inc is a good buy right now due to its strong recent performance and positive financial indicators. The current price is $138.43, and the company reported a profit of $162.8 million in Q2 2026, translating to an EPS of $2.29. Additionally, analysts have set a price target of $190, indicating a potential upside of approximately 37% from the current price. However, there is a risk with insider selling increasing by 7175.14% over the last month, which could signal caution among company executives.
PTGX cerró en $141.12 el Tuesday, tras subir +0.57%
Protagonist Therapeutics Inc (PTGX) last closed at $141.1199951, gaining +0.57%. These facts feed the 1-day and 1-week PTGX price prediction above.
Consenso de analistas
Protagonist Therapeutics Inc (PTGX): 4 comprar, 0 mantener, 0 vender. Perspectiva: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Factores de la previsión
Los factores de la previsión de Protagonist Therapeutics Inc (PTGX) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bullish
SMA 200
Bullish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de PTGX, ordenadas por similitud.
Análisis de estacionalidad de PTGX
Historically the probability of a positive October return for PTGX is 100.00%. April offers the highest probability of a positive month at 100.00%, while January is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de PTGX
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Oct 2026 | $49.63 | $64.05 | $72.45 | -54.61% |
| Nov 2026 | $61.01 | $76.05 | $90.62 | -46.11% |
| Dec 2026 | $40.24 | $55.78 | $69.30 | -60.47% |
En 2026, se proyecta que Protagonist Therapeutics Inc (PTGX) oscile entre $40.24 y $90.62.
Previsión mensual de Protagonist Therapeutics Inc para 2026
En Oct de 2026, se proyecta que Protagonist Therapeutics Inc promedie $64.05, con un mínimo de $49.63 y un máximo de $72.45.
En Nov de 2026, se proyecta que Protagonist Therapeutics Inc promedie $76.05, con un mínimo de $61.01 y un máximo de $90.62.
En Dec de 2026, se proyecta que Protagonist Therapeutics Inc promedie $55.78, con un mínimo de $40.24 y un máximo de $69.30.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.